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Abstract.  A  365-bp fragment from the 5' region of 
the human transferrin receptor gene has been sub- 
cloned and sequenced.  This fragment contains 115 bp 
of flanking sequence, the first exon, and a portion 
of the first intron. It contains a TATA box,  several 
GC-rich regions, and is able to efficiently promote ex- 
pression of the bacterial CAT gene in mouse 3T3 cells. 
Sequence comparisons demonstrate that this DNA seg- 
ment has homology to the promoter regions of the hu- 
man dihydrofolate reductase gene and the mouse inter- 
leukin 3 gene, as well as to a  monkey DNA sequence 
that has homology to the SV40 origin and promotes 
expression of an unidentified gene product.  Several 
high molecular mass proteins that interact with the 
transferrin receptor gene promoter have been 
identified. The activity of these proteins is transiently 
increased in 3T3 cells that have been stimulated by 
serum addition. This increase precedes a  rise in trans- 
fen-in receptor mRNA levels in the cytoplasm, which 
in turn precedes entry of the cells into S phase. 
DNase I  footprinting of the transferrin receptor pro- 
moter reveals several protein binding sites.  Two of the 
sites are within the conserved GC-rich region of the 
promoter.  One of these binding sites probably interacts 
with Spl,  while the second interacts with an uncharac- 
terized protein. 
C 
ELLS are  provided with  the  essential  nutrient iron 
through the  action  of transferrin receptors  (TR).1 
Surface receptors and iron-loaded transferrin are in- 
ternalized to acidic intraceUular vesicles where the iron is 
released. The receptor and apotransferrin are then recycled 
to the cell surface and reutilized. Through this process, intra- 
cellular iron is available  for heme-containing proteins, ox- 
idative enzymes,  and other  iron-requiring  enzymes.  The 
requirement for iron in many physiological processes neces- 
sitates the presence of a low level of TR on nearly all cell 
types. However, under certain conditions, the number of cell 
surface receptors is greatly increased. In maturing reticulo- 
cytes a large supply of intracellular iron is needed for hemo- 
globin synthesis. This need is met by expression of a large 
number of cell surface TR. Likewise, when erythroleukemia 
cells are induced to differentiate in vitro, there is a several- 
fold increase in TR number that precedes the production of 
hemoglobin (15). The  number of cell  surface TR is also 
greatly increased in rapidly proliferating cells (21, 40,  13). 
Many  transformed  cells  have  an  elevated  level  of  TR. 
Mitogen-stimulated  lymphocytes and  fibroblasts  increase 
their cell surface TR manyfold. In contrast, when induced 
to differentiate, most cell types stop cell division and display 
a sharp reduction in TR number (37). 
The marked increase in TR levels in proliferating cells ap- 
pears to be a necessity for DNA synthesis. Functional recep- 
1. Abbreviations  used in this paper:  DHFR, dihydrofolate reductase; TR, 
transferrin receptor. 
tors are required for the cell to complete S phase (30, 39). 
When treated with mAbs that bind to the TR, cells are pre- 
vented from growing and accumulate in S phase (39).  This 
effect is not overcome by supplying other forms of iron to the 
cell, and appears to be related to receptor aggregation at the 
cell surface (22). 
As a protein that is expressed at elevated levels in prolifer- 
ating cells and provides an important S phase function, the 
TR belongs to a group of similarly expressed proteins and 
enzymes. Included in this group of proteins are the enzymes 
of deoxynucleotide biosynthesis and DNA replication. The 
levels of mRNA coding for many of these enzymes, as well 
as for TR, have been shown to increase upon mitogen stimu- 
lation. This suggests  that common regulatory mechanisms 
may control expression of the genes coding for this class of 
proteins. Such mechanisms may be both transcriptional (14, 
9) and posttranscriptional (23, 12). Our aim is to define the 
molecular nature of these controls. Here we present the se- 
quence of the human TR gene promoter, a striking homology 
of this sequence with the dihydrofolate reductase (DHFR) 
gene promoter and the interleukin 3 gene promoter, and the 
mitogen-dependent expression of a group of proteins that in- 
teract with defined regions of this sequence. 
Materials and Methods 
Plasmid Construction and DNA Sequencing 
A 365-bp Sal I/Xho I fragment from the 5' end of the human genomic se- 
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of MI3 mp9 using standard procedures. Clones containing the insert in both 
orientations were isolated and sequenced by the dideoxy chain termination 
procedure. The sequence was independently confirmed by the method of 
Maxam and Gilbert (25). 
To construct CAT expression plasmids using the TR365  fragment, the 
purified Sal I/Xho I fragment was converted to a blunt-ended fragment by 
end-filling with the Klenow fragment. HindlIl linkers were ligated to the 
fragment, which was then digested with HindIIl and gel-purified to remove 
excess linkers. The fragment was ligated to HindlII-digested pSVO CAT 
(11), which had been treated with alkaline phosphatase. The mixture was 
used to transform Escherichia coli HB 101. Plasmids containing the 365-bp 
fragment in the two different orientations with respect to the CAT gene were 
identified by restriction analysis and Maxam/Gilbert sequencing. 
Transient Expression Assays 
20 Ixg of plasmid DNA was added as a  calcium phosphate precipitate to 
150-mm z tissue culture flasks containing 1 x  106 Swiss/3T3  cells that had 
been plated 24 h earlier. The medium was replaced after 24 h and the cells 
harvested after 48 h. The cells were resuspended in 100 ~tl of 0.25 M Tris- 
C1, pH 7,8. The cells were disrupted by three freeze-thaw cycles and debris 
was pelleted by centrifuging for 2 rain in an Eppendorf  microcentrifuge. Ex- 
tracts were either assayed immediately for CAT activity or stored frozen at 
-20°C. 
CAT assays were carried out by the method of Gorman et al. (11). Reac- 
tions contained 0.5 M Tris-Cl, pH 7.8, 0.5 mM aeetyl eoenzyme A, 1 #2i 
[~4C]chloramphenicol,  and 30 ~tl of extract in a volume of 150 I.tl. They 
were incubated at 37°C for 60 min. Chloramphenicol was extracted in ethyl 
acetate and dried under vacuum. The sample was redissolved in 20 Ixl of 
ethyl acetate, spotted on a silica gel thin layer plate, and chromatographed 
in chloroform/methanol (95:5). The plate was then exposed to Kodak XAR- 
5 film. 
Low Ionic Strength Polyacrylamide Electrophoresis 
and DNase I Footprinting 
A labeled fragment for footprint analysis was prepared by digesting pTR- 
CAT-16 with Taq I and end-filling with Klenow fragment in the presence of 
[32P]dCTP. The  DNA  was  recovered by  ethanol precipitation and then 
digested with Ava I. The appropriate fragment was gel-purified by agarose 
electrophoresis and electroelution. The electroeluted fragment was bound 
to a  1-cm column of DEAE-Sephacel in a Pasteur pipette and eluted with 
1 M  NaC1,  6.5  M urea,  10 mM Tris-C1,  pH 7.6. The fragment was then 
ethanol-precipitated and redissolved in HzO. 
Protein-DNA complexes were analyzed by a procedure similar to  that of 
Fried and Crothers (10). Binding reactions (20 ~tl) contained 10 mM Hepes, 
pH 8.0, 60 mM KC1, 5 mM (NH4)2SO4, 5 mM MgCI2,  5% polyethylene 
glycol (PEG),  1 mM dithiothreitol (DTT),  1 lag poly(dI-dC).poly(dI-dC), 
0.2 ~tg plasmid DNA, 0.5 ng end-labeled probe, and 0-10 ~tg HeLa nuclear 
extract prepared by the procedure of Dignam et al. (5). Incubation was car- 
ried out on ice for 30 min. The samples were then applied to gels composed 
of 3.5% acrylamide, 10 mM Hepes, pH 8.0, and 0.5 mM EDTA. The elec- 
trode buffer consisted of 10 mM Hepes, pH 8.0, 0.5 mM EDTA. Electropho- 
resis was done at 200 V for •2  h. 
Footprinting reactions (50 I~1) contained 10 mM Hepes, pH 8.0, 60 mM 
KC1,  5  mM (NH4hSO4,  5  mM  MgCI2,  5%  PEG,  1 mM DTT,  2.5  lxg 
poly(dI-dC).poly(dl-dC), 0.5 ~tg plasmid DNA, 50 ng of  end-labeled probe, 
and ,x,10 ~tg of HeLa cell nuclear extract. Incubation was carried out on ice 
for 30 min. The samples were then placed at room temperature and 5 ~tl 
of 5-50 ~tg/ml DNase I in 10 mM CaCI2 was added. After 1 min the reac- 
tions were stopped by adding EDTA to 50 mM and placing the samples on 
ice.  Protein-DNA complexes were resolved on polyacrylamide gels as 
above. The wet gels were exposed to XAR-5 film for 1-2 h. The radioactive 
bands were excised from the gel and incubated overnight in 0.1 mM EDTA, 
0.1% SDS, and 0.5 M ammonium acetate. The acrylamide was removed and 
the DNA  fragments recovered by ethanol precipitation.  The  DNA  was 
resuspended in 90% formamide and 10 mM NaOH, heated to 90°C for 10 
rain and loaded on a 7 % sequencing gel. 
Protein Blotting 
Protein blotting experiments were carried out as described (28) except that 
nuclei  were lysed directly in  SDS-containing sample buffer.  DNA  was 
sheared by pipetting and the sample directly loaded on the polyacrylamide 
gel. 
Results 
The TR Gene Promoter 
The TR gene is 33-kbp long and consists of at least 19 exons 
(20,  26).  Less than 200 bp 5' of the first exon are required 
for the human gene  to be  expressed  in  mouse Ltk-  cells 
(20). This suggested that promoter elements were contained 
within this short DNA sequence. We have subcloned and se- 
quenced a 365-bp sequence that contains 115 nucleotides up- 
A 
1  GATCTTGTCA  AGCACCTCGC  GAGCGTACGT  GCCTCAGGAA  GTGACGCACA  GCCCCCCTGG 
61  GGGCCGGGGG  CGGGGCCAGG  CTATAAACCG  CCGGTTAGGG  GCCGCCATCC  CCTCAGAGCG 
121  TCGGGATATC  GGGTGGCGGC  TCGGGACGGA  GGACGCGCTA  GTGTGAGTGC  GGGCTTCTAG 
181  AACTACACCG  ACCCTCGTGT  CCTCCCTTCA  TCCTGCGGGG  CTGGCTGGAG  CGGCCGCTCC 
241  GGTGCTGTCC  AGCAGCCATA  GGGAGCCGCA  CGGGGAGCGG  GAAAGCGGTC  GCGGCCCCAG 
301  GCGGGGCGGC  CGGGATGGAG  CGGGGCCGCG  AGCCTGTGGG  GAAGGGGCTG  TGGCGGCGCC 
361  TCGAG 
AUG 
B  ,ArA  -----  l  .  l 
l  i  I  i-'--~  I  -"  =-ate  =  =  ,,  , 
Figure 1. Nucleotide sequence of the 5' region of human TR gene. (A) The sequence of a 365-bp fragment that contains 115 bp of 5' flanking 
sequence, an untranslated exon, and part of the first intron.  (B) A  diagram of the relevant features is shown. Open boxes indicate exon 
sequences. Closed boxes indicate the GGGGC  repeats.  The slash indicates the 3' end of the sequence above. 
The Journal of Cell Biology, Volume 103, 1986  1782 stream of the mRNA start site, the first exon, and part of the 
first intron (Fig. 1 A). A map illustrating the relevant features 
of this  fragment (TR365) is  shown in  Fig.  1 B.  A  TATA 
box is present 27 +  2 bp upstream of the transcriptional start 
site,  deduced  from the  primer  extension  experiments  of 
Schneider et al. (36). Upstream of the TATA box is a highly 
GC-rich region that consists largely of four repeats of the se- 
quence GGGGC. These are arranged as one inverted copy 
followed by three direct repeats of this sequence. An addi- 
tional six copies of the sequence GGGGC occur within the 
TR365 fragment for a  total of 10 repeats of this pentamer 
within the 300 bp surrounding the mRNA start site. In com- 
parison, the sequence GGGGC occurs only once in 5 kb of 
the TR cDNA, emphasizing the unusually high frequency of 
this sequence at the 5' end of the TR gene. 
As a first step in defining regulatory elements within the 
TR365 fragment, we have used the bacterial CAT (chloram- 
Figure 2. Promoter activity of the 365-bp fragment from the 5' end 
of  the TR gene. The plasmids indicated above each lane were intro- 
duced into Swiss/3T3 cells by calcium phosphate precipitation. The 
promoter efficiency of each construct was measured by assaying 
CAT activity 48 h after transfection, pSVO-CAT is a negative con- 
trol that lacks a promoter sequence 5' to the CAT gene. pSV2-CAT 
contains the SV40 early promoter and enhancer sequences (Gor- 
man et al.,  1982). pTR-CAT-16  contains the TR 365-bp fragment in 
the 5'-3' orientation with respect to the CAT gene, while pTR-CAT- 
18 contains the same fragment in the opposite orientation. In the 
lane labeled CAT, the assay contained purified CAT enzyme and 
(-) indicates [~4C]chloramphenicol  alone. The origin is at the bot- 
tom of the figure. 
phenicol acetyltransferase) gene  system to  assay  for pro- 
moter function.  The TR365  sequence was cloned in both 
orientations into the HindlII site of pSVO-CAT (11) to gener- 
ate the plasmids pTR-CAT-16 and pTR-CAT-18. The plasmids 
were introduced into Swiss/3T3 cells by calcium phosphate 
precipitation. Cell extracts were made 48 h later and assayed 
for CAT activity (Fig. 2). The plasmid pTR-CAT-16, which 
contains the TR365 fragment in the 5'-3' orientation with re- 
spect to the CAT gene, showed a significant level of expres- 
sion when compared with the negative control, pSVO-CAT, 
which lacks a promoter sequence. In the opposite orientation 
(pTR-CAT-18) TR365 displayed no promoter activity. While 
the promoter activity of the TR365 sequence is somewhat 
lower than that of pSV2-CAT,  we have observed that placing 
the  SV40  72-bp  repeats  downstream  of the  CAT  gene in 
pTR-CAT-16 elevates the expression to a  level comparable 
to pSV2-CAT.  These experiments demonstrate that elements 
within the TR365 sequence display a strong mammalian pro- 
moter activity. 
Sequence Homologies to the TR Promoter 
As noted above, the stretch of GC bp just upstream from the 
TATA box in the TR gene is comprised of four repeats of the 
sequence GGGGC, three direct and one inverted (Fig. 3). A 
similar pattern of repeats has been reported in several other 
genes (32, 41, 29).  The human DHFR gene contains a se- 
quence that is homologous with the three direct GGGGC 
repeats of the TR gene (Fig.  3).  Notably,  the DHFR se- 
quence is in an identical location to the TR repeats just up- 
stream from the TATA-like sequence. Similarly, the murine 
interleukin 3  gene contains a  homologous GC-rich region 
that is also just 5'to the TATA box. In this gene the first three 
GGGGC repeats going upstream from the TATA box are in- 
verted from those found in the TR gene. A DNA segment 
(pCaOri7.01)  that was isolated from monkey cells by its ho- 
mology to the SV40 origin region and is known to promote 
bidirectional transcription of  the adjacent genes (34) also has 
homology to the GGGGC repeats of the TR gene. This DNA 
fragment does not contain a TATA box but does have three 
direct GGGGC repeats. In addition, the conserved GC-rich 
region in each of these genes contains at least one consensus 
Spl binding site (GGGCGG) as defined by Dynan and Tjian 
(8). 
The biological significance of the conserved sequence de- 
scribed above is unknown. It is significant, however, that in 
three genes the repeats are located in nearly identical posi- 
tions in relation to the TATA boxes and the transcriptional 
initiation sites. In addition, all three genes code for products 
that are induced by mitogenic stimulation.  One hypothesis 
suggested by these observations is that the conserved GC- 
rich sequences represent cis-acting regulatory sequences in- 
volved in activation of a class of genes that respond to com- 
mon signals during the progression of cells to S phase. 
Protein Binding Sites within the GC-rich 
Flanking Sequence 
To test  the  hypothesis  suggested  by  the  observations  de- 
scribed above, we have begun to analyze the DNA-protein in- 
teractions within the TR gene promoter (28).  The sites of 
protein  binding  within  this  region  have  been  defined by 
DNase I footprinting. A double-stranded probe was prepared 
Miskimins et al.  Transferrin Receptor  Gene Promoter  1783 TR  5'  GCACA~CCCCCCTGGGGGCCGGGGGCGGGG~AGGCTATAAACCGCCGGTTAGGGGCCGCCAT 
3'  CGTG~CGGGGGGACCCCCGGCCCCCGCCCCG~TCCG~GGCGGCCAATCCCCGGCGGTA 
DHFR  5'  ACCCTGCGTGCGC~GGGCGGGGGG~GGGG~TCGCCTGCACAAATAGGGACGAGGGGGCGG 
3'  TGGGACGCACGCG~CCCCGCCCCCCCGCCCCG~AGCGGACGTGTTTATCCCTGCTCCCCCGCC 
IL3  5'  TGCCC~CCCCCCTGCCCCG~GCCC~~ACCCCTCTCTGAATACATATAAGGTGAAGGC 
3'  ACGGG~GGGGGGACGGGGCGGCCGGGGCGGG~TGGGGAGAGACTTATGTATATTCCACTTCCG 
pCaOri7.01  5'  GGCTAGTGCCGGC~GGGGGGC--GGGGCGGG~GAGGGCGGGGTGGACGTGGCACCTGGTTGC 
3'  CCGATCACGGCCqCCCCCCGCCCCGCCCCCC~CCTCCCGCCCCACCTGCACCGTGGACCAACG 
TR  ......  a  i  ~  m'-  =  ---TATAAA 
DHFR  "-  -~  -  CACAAA 
IL3  ~  ~-  ~-  .................  TATAA ......... 
pcaori7.01  ~  ~ 
Figure 3. TR promoter has homology to other promoters. The promoter regions of human DHFR, mouse intedeukin 3 (IL3), and a monkey 
promoter from a functionally undefined gene (pCaOri7.01) were found to have GC-rich regions homologous to the TR promoter. The regions 
of homology are boxed. The TATA  boxes are underlined. The diagram at the bottom of the figure shows the direction of the GGGGC 
repeats relative to the TR sequence. 
by cleaving the pTR-CAT-16 plasmid with Taq I, labeling the 
ends with 32p using the Klenow fragment of polymerase I, 
cleaving with Ava I, and purifying the labeled fragment by 
preparative agarose electrophoresis. This procedure resulted 
in a  140-bp fragment labeled on the 3' end of the template 
strand containing the GC-rich region of the promoter and ex- 
tending 53  bp downstream of the  TATA box.  Complexes 
formed between this probe and nuclear proteins from HeLa 
cells were analyzed by low ionic strength polyacrylamide 
electrophoresis (10). Complexes of two different mobilities 
could be detected by this procedure (Fig. 4). At the highest 
protein concentrations (Fig. 4, lanes 4 and 5) a protein-DNA 
complex (complex II) that migrated only a short distance into 
the acrylamide gel was formed. At lower protein concentra- 
tions (Fig. 4, lanes 2 and 3), however, a complex with inter- 
mediate mobility (complex I) was observed. The two com- 
plexes observed may represent protein binding to multiple 
sites  within the  sequence and  is  consistent with previous 
findings (38). Complex I was subjected to further analysis by 
DNase I footprinting experiments that were carried out using 
a procedure similar to that described by Carthew et al. (2). 
The labeled probe was incubated with a crude HeLa cell nu- 
clear extract (5) and then partially digested with DNase I. 
DNA-protein complexes were separated by electrophoresis 
on low ionic strength polyacrylamide gels (see Materials and 
Methods) and detected by autoradiography. DNA fragments 
were  extracted  from  the  gel  slices  and  analyzed on  7% 
acrylamide sequencing gels. The results are shown in Fig. 
5. Two regions of protection are clearly observed. The first 
region covers 22 bp just upstream of the TATA box. The pro- 
tein binding to this binding site protects much of the con- 
served GC-rich  region  described  above.  Precisely  in  the 
center of this region is a consensus Spl recognition sequence 
(8). It is therefore likely that protection in this region is due 
to this protein. Also noteworthy in this experiment is that en- 
hanced cleavage sites on both sides of the protected region 
are induced by protein binding. The second protected region 
covers a 22-bp sequence just upstream from the first. This 
Figure  4.  TR promoter  DNA- 
protein complex formation.  A 
140-bp  DNA  fragment  con- 
mining the 5' flanking region of 
the TR gene promoter, includ- 
ing the conserved GC-rich se- 
quence and the TATA  box, and 
25 bp of the first exon was la- 
beled with np at the 3' end of 
the template strand. Complexes 
between  this  fragment  and 
HeLa cell nuclear proteins were 
analyzed on  3.5% acrylamide 
gels. Lanes 1-5 contain 0,  1, 3, 
5, and 10 ~tg of nuclear extract 
proteins, respectively. The posi- 
tion of unbound DNA probe is 
marked by (0). 
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region and extends some distance upstream as well. Again, 
enhanced cleavage sites flank the protein binding site.  This 
protected site has the sequence GCTGTGCGTC at its center. 
A homologous sequence is found in a similar location in the 
human DHFR promoter (see Fig.  8 and Discussion). 
Mitogen-dependent Stimulation of  Proteins that 
Interact with the TR Promoter 
It has been shown that the level of cell surface TR is greatly 
increased in rapidly proliferating cells (21, 40). This increase 
in surface receptors coincides with an increase in mRNA, 
which codes for the receptor (31, 4), suggesting that receptor 
levels are under transcriptional or posttranscriptional con- 
trol.  There  is  increasing  evidence  linking  transcriptional 
control  in  eukaryotes  with  sequence-specific  trans-acting 
DNA binding proteins. We have identified several high mo- 
lecular weight proteins that interact with the  365-bp frag- 
ment that contains the TR gene promoter (28).  These pro- 
teins  bind  with  high  affinity  and  specificity to  this  DNA 
fragment. The in vivo significance of these protein-DNA in- 
teractions  is at present unknown.  However, if they are in- 
volved in transcriptional control of the receptor gene, their 
activity may be modulated by mitogen stimulation of cell 
growth.  We  have tested  this  idea  using  Swiss/3T3  mouse 
fibroblasts. These cells were allowed to become quiescent by 
growing to confluence in 5 % FCS followed by a 5-d incuba- 
tion without a change of medium. The quiescent cells were 
then stimulated to grow by changing to medium containing 
15 % FCS.  At the times indicated,  nuclei were isolated and 
DNA-protein binding to the TR gene promoter was studied 
as previously described (28). This method involves separat- 
ing  the  proteins  by  SDS-polyacrylamide  electrophoresis, 
transferring the proteins to nitrocellulose, and incubating the 
immobilized  proteins  with  specific  labeled  DNA  probes. 
Proteins of apparent molecular masses of 120, 105, and 95 
kD are detected  at significant levels in  the quiescent  cells 
(Fig. 6).  Each of these proteins is induced to a higher level 
by serum stimulation, all reaching a maximum DNA binding 
activity at  ~3  h  after increasing the  serum concentration. 
Between 3  and  12  h  poststimulation,  there is a  very rapid 
drop in the level of these three proteins, with almost no de- 
tectable activity beyond  18 h. 
The binding activity of an 88-kD protein is quite different. 
Almost no binding to the TR365  probe is observed in the 
nuclei of quiescent cells. Upon serum stimulation, the activ- 
ity is rapidly induced and reaches a maximum after '~6 h. 
Again, between 6 and  18 h after increasing the serum con- 
centration there is a rapid decline in the level of this protein. 
Fig. 7 compares the effect of serum stimulation on the 88- 
Figure 5. Footprint analysis. DNA-protein complexes were treated 
with DNase I and separated on 3.5% acrylamide gels as in Fig. 4. 
Complex I was excised from the gel and the DNA fragments eluted 
and analyzed on 7% acrylamide-8.3  M urea sequencing gels. The 
lanes are (G) Maxam/Gilbert DNA sequence marker; (-) no pro- 
tein added;  (+) 7.5  I.tg HeLa nuclear extract protein added.  The 
protected sequences are shown at the right. Brackets mark the GC- 
rich conserved sequence (Fig. 3). The TATA  box and consensus Spl 
binding  sequences  are  indicated.  The  arrows  indicate  DNase- 
sensitive sites induced by protein binding.  Note that the sequence 
shown is the template strand and therefore complimentary to the se- 
quence shown in Fig.  1. 
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the TR gene promoter. Quiescent Swiss/3T3 cells were stimulated 
with 15 % FCS. At the times (h) indicated above, each lane nuclear 
proteins were extracted and fractionated by SDS PAGE. The pro- 
teins were electrophoreticaUy transferred to nitrocellulose and in- 
cubated with the  32p-labeled TR promoter  as described  (Miski- 
mins et al.  [28]). 
kD  nuclear  protein  to  induction  of cytoplasmic  mRNA, 
which codes for the TR and the induction of DNA synthesis. 
DNA synthesis begins ~12 h after increasing the serum con- 
centration to  15%  and  reaches a  maximum  at  24  h.  TR 
mRNA is present at a low level in the cytoplasm of quiescent 
cells and increases severalfold upon stimulation, reaching a 
maximum near the onset of DNA synthesis.  This result is 
consistent with previous reports (31, 4). The activity of the 
88-kD nuclear protein that interacts with the TR gene pro- 
moter  reaches  a  maximum  just  before  the  increase  in 
cytoplasmic mRNA. 
Discussion 
The human TR gene is one of many genes that have highly 
GC-rich promoter regions. This group includes the genes for 
DHFR,  arginosuccinate synthetase,  adenosine deaminase, 
HPRT, HMG-coenzyme A  reductase, metallothionein, in- 
terleukin 3,  type II procollagen,  epidermal growth factor 
receptor, APRT, superoxide dismutase, and others. This dis- 
parate group of genes has no obvious relationship in terms 
of expression patterns or function of their products. Many of 
these genes are expressed in multiple cell types and often 
lack  TATA  and  CAAT  boxes  in  the  GC-rich  5'  flanking 
regions. It has been suggested that promoters with this struc- 
ture allow constitutive, low level expression of  the gene prod- 
ucts (27, 33). A subset of genes with GC-rich promoters, in- 
cluding the TR gene, code for products that are expressed at 
increased levels during the transition from quiescence to ac- 
tive cell growth.  We  have shown here that  several of the 
promoters for these mitogen-responsive genes contain com- 
mon sequence motifs, suggesting a common mode of regula- 
tion. Although we have not yet analyzed the transcriptional 
rates of the TR gene, we and others (31, 4) have observed an 
increase in TR message after mitogen stimulation. A similar 
increase in message for several other gene products that are 
required for entry into S phase of the cell cycle has been ob- 
served (35,  9, 3, 24,  16). Increased levels of DHFR mRNA 
in serum-stimulated cells is due in part to enhanced tran- 
scriptional levels (35,  9), and the DHFR promoter has ho- 
mology to the TR promoter.  We have therefore begun an 
analysis of the factors that control expression of the TR gene 
and other coordinately regulated genes. 
A common feature of these GC-rich promoters is the pres- 
ence  of the  hexanucleotide GGGCGG,  often  in  multiple 
copies. This sequence is the recognition site for the HeLa 
cell transcription factor Spl (8). This protein has been shown 
to enhance transcription in vitro from several promoters, in- 
cluding the SV40 early promoter (8) and the HSV-thymidine 
kinase promoter (18). A  single copy of this hexanucleotide 
is present upstream of the TATA box in the TR gene pro- 
moter. It is found within the GC-rich region that is conserved 
in the TR, DHFR, and interleukin 3 genes (see Fig. 3). We 
have observed a strong protein binding site within this region 
using  DNase  I  protection assays.  The  Spl  consensus  se- 
quence is precisely in the center of this binding site and it 
is most likely that protection is due to Spl binding. It has been 
shown that Spl does not bind tightly to every GGGCGG se- 
quence  and  that  the  affinity  is  enhanced  by  flanking  se- 
quences on both sides of this hexanucleotide. The best bind- 
ing sites  for Spl  are the sequences G4CG4C or  TG3CG4C 
(19). The high affinity site G4CG4C is found in the protected 
region of the TR promoter, strengthening the conclusion that 
the binding we observe is due to Spl. Furthermore, Spl bind- 
ing to an analagous sequence in the mouse DHFR gene and 
to the monkey promoter in pCaOri7.01 has also been demon- 
strated (7, 6). 
We have observed a second protein binding site, just up- 
stream of the consensus Spl binding site, that overlaps the 
conserved GC-rich region. In the core of this protected re- 
gion the sequence GCTGTGCGTC is  found. A  related se- 
quence is found in a  similar position in the human DHFR 
gene, although in the opposite orientation (Fig. 8). Eight of 
nine nucleotides in the DHFR match the sequence of this TR 
promoter protein binding site: 
5'  GCTGTGCGPyC  TR 
II  IIIII  I 
5'  GC-GTGCGPyC  DHFR 
We can speculate that the protein that binds to this site may 
interact with Spl to modulate the transcriptional activity of 
the TR and other genes (such as DHFR) that are coordinately 
regulated. The promoters of these genes may function in a 
manner analagous to the HSV-thymidine kinase promoter, 
which requires, in addition to Spl, a second factor (CTF) for 
optimal activity (18). Alternatively, it is possible that Spl al- 
lows constitutive, low level expression of the TR gene in 
most cells, while the additional promoter binding proteins 
stimulate increased production of TR in proliferating cells. 
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Figure  7. Stimulation of DNA synthesis, TR mRNA, and 88-kD protein by serum.  Quiescent Swiss/3T3 ceils were induced to undergo 
mitosis by raising the serum concentration in the medium to 15%. DNA synthesis (solid triangle) was monitored by assaying the incorpora- 
tion of [3H]thymidine into TCA-insoluble material. The level of TR mRNA (open circle)  was determined using dot blot hybridization as 
described  by Bresser  et al.  (1). The binding  activity  of the  88-kD protein  (solid circle;  see Fig.  6)  was quantitated by scanning the 
autoradiograph  with a densitometer. 
In preliminary experiments we have identified two addi- 
tional protein binding sites in the TR promoter immediately 
upstream of the two sites described above (data not shown). 
The multiple sites of protein interaction suggest a complex 
mechanism for regulation of TR expression. Purification of 
the proteins involved and demonstration of their effects on 
transcription in vitro and in vivo will be required to fully un- 
derstand their involvement in TR gene expression and cell 
proliferation. 
Using  a  protein  blotting  procedure,  we  have  identified 
several proteins that appear to bind strongly to the TR pro- 
moter (28).  It is unknown at present whether any of these 
proteins recognize the specific sequences described above or 
if they have any physiological relevance to TR gene expres- 
sion. Jones et al. (17) have recently demonstrated that Spl has 
an apparent Mr of 95 kD on SDS-polyacrylamide gels. It is 
possible therefore, that the 95-kD protein that we detect by 
protein blotting is Spl. It is also intriguing that the binding 
activity of one of the proteins (88 kD) detected by this proce- 
dure is induced by mitogen action, as is the TR itself. The 
level of binding activity of this protein parallels the increase 
in TR mRNA after serum stimulation of 3T3 cells (Fig. 7). 
It will be of interest to further characterize this protein in or- 
der to establish whether or not it plays a role in TR expres- 
sion or has any significance in cell growth control. 
The observation that there is conserved sequence homol- 
ogy  in  the  promoters  of the  TR  gene  and  several  other 
mitogen-responsive genes, along with the demonstration that 
these conserved sequences serve as sites for protein interac- 
tions in the TR promoter,  suggests a mechanism for coor- 
TR 
DHFR 
TR  PROTECTED 
REGION  SpI  TATA  BOX  S'G ACGCACAGq CCCCTGGGGG           q       
CA~TG  CG  TGTCG~GGGGACCCCCGG  C~CCCGCCCCC~G  TCCC~ATAT  Tq]GG 
D 
5*C~GCG  TGCGCC~GGGCGGG~GGG  CGGGGC~TCGCCT~AG 
G CGCACGCGqCCCCGCCqccccGccCC AGCGGAqGTGTT TC 
I 
Figure 8.  Comparison  of protein 
binding sites in the TR gene pro- 
moter with the DHFR promoter 
sequence. 
Miskimins et al.  Transferrin  Receptor Gene Promoter  1787 dinate gene expression during cell growth. As more genes 
within this class are cloned and sequenced, and as the pro- 
teins involved are purified and characterized, it will be possi- 
bleto systematically test this hypothesis and its implications 
for control of cell growth. 
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